Comparing Heterologous and Homologous COVID-19 Vaccination: A Longitudinal Study of Antibody Decay
Description
The humoral response after vaccination was evaluated in 1248 individuals who received different COVID-19 vaccine schedules. The study compared subjects primed with adenoviral ChAdOx1-S (ChAd) and boosted with BNT162b2 (BNT) mRNA vaccines (ChAd/BNT)
